A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model.
一项关于使用前蛋白转化酶枯草杆菌蛋白酶/Kexin 9 型抑制剂 PEP 2-8 减轻大鼠边缘供体模型缺血性损伤的临床前研究。
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26188937
Grignano Maria Antonietta, Gregorini Marilena, Barisione Chiara, Ivaldo Caterina, Verzola Daniela, Rumeo Noemi, Malabarba Stefano, Mimmi Maria Chiara, Montatixe Fonseca Elizabeth Carolina, Viglio Simona, Iadarola Paolo, Islami Tefik, Pattonieri Eleonora Francesca, Ceccarelli Gabriele, Picciotto Daniela, Pratesi Giovanni, Viazzi Francesca, Stea Emma Diletta, Arbustini Eloisa, Esposito Pasquale, Rampino Teresa
